Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)

Investor
Center

Announcements

Group 9Created with Sketch.

Opyl Board and Management Change

download
Group 9Created with Sketch.

Opyl Appendix 3Y Change of Director's Interest - D Rasheed

download
Group 9Created with Sketch.

Opyl response to ASX Questions

download
Group 9Created with Sketch.

Opyl achieves major milestone with AI platform

download
Group 9Created with Sketch.

Appendix 4E & Full Year Statutory Accounts

download
Group 9Created with Sketch.

Opyl Investor Update - August 2020

download
Group 9Created with Sketch.

Opyl Notice of Change of Interests of Substantial Holder

download
Group 9Created with Sketch.

Opyl Change of Director's Interest

download

News

Group 9Created with Sketch.

Opyl’s artificial intelligence will change clinical trials forever

download
Group 9Created with Sketch.

Radical rebirth for Opyl as focus switches from user-generated content to health and life sciences

download

Annual Reports

Group 9Created with Sketch.

SRO Annual Report 2019

download
Group 9Created with Sketch.

Annual Report 2018

download
Group 9Created with Sketch.

Annual Report 2017

download

Quarterly Reports

Group 9Created with Sketch.

Opyl Appendix 4C – Quarter (Q1) ending 30 September 2020

download
Group 9Created with Sketch.

Q4 Report and Appendix 4C 2020

download
Group 9Created with Sketch.

Q3 Report and Appendix 4C 2020

download
Group 9Created with Sketch.

Q2 Report and Appendix 4C 2020

download

Share Registry

Automic Share Registry

1300 288 664

Presentations

Group 9Created with Sketch.

Investor Update - June 2019

download
Group 9Created with Sketch.

Investor Update - Oct 2019

download
Group 9Created with Sketch.

AGM Investor Update - Nov 2019

download